HBV Articles
Back
 
SAVE-1: Phase 2 Results of a Novel Active Site Polymerase Inhibitor Nucleotide (ASPIN), ATI-2173 + TDF in HBV-Infected Patients
APASL 2022 March 30 -April 3
View Older Articles
Back to Top
www.natap.org